Why LightSpeed (TSX:LSDP) & Ocugen Are Trending in Canadian Markets?

3 min read | December 23, 2020 09:07 PM AEDT | By Kunal Sawhney

Summary

  • Ocugen stocks jumped nearly 174 per cent on December 22, guided by its partnership with Bharat Biotech to co-develop COVID-19 related vaccine for the US pharma market.
  • Ocugen’s 734 million scrips changed hands in a single trading session. The biopharma firm stocks have swelled 100 per cent in 2020.
  • LSPD stocks have added almost 141 per cent growth year-to-date. The SaaS platform provider has outperformed the North American industry, as per its exchange filing.

 

The US-based biopharma firm Ocugen, Inc. (OCGN: US or NASDAQ: OCGN) and an India-based biotech firm Bharat Biotech on December 22, announced that they will co-develop inactivated COVID-19 vaccine candidate – COVAXIN™ – to an advanced level for the United States market. COVAXIN™ has already shown safety and immunogenicity data in Phase 1 and Phase 2 studies. Ocugen stocks rocketed nearly 174 per cent on the back of this collaboration news.

Lightspeed POS Inc. (TSX:LSPD), a Canadian software company, joined the US tech rally with an 11.5 per cent surge on December 22. The cloud-based service provider has been successfully leading its operations across North America through digital innovations. The SaaS platform has gained more clients throughout the United States and Canada in September 2020, a year-over-year increase of 23 per cent and 26 per cent, respectively.

Let us have a look at the stock and financial performance of these two trending companies:

 

Ocugen, Inc. (OCGN: US or NASDAQ: OCGN)

Current Stock Price: US$ 0.805

 

The clinical-stage biopharmaceutical firm stock has zoomed over 160 per cent in the last three months. The healthcare firm stocks have yielded approximately 100 per cent returns year-to-date (YTD). Its 10-day average stock trading volume has reached almost 74.5 million units, led by its latest collaboration with Bharat Biotech.

The stock is offering earnings per share of US$ 3.80. The biopharma stock holds a present price-to-book (P/B) ratio of 8.947, and a debt-to-equity (D/E) ratio of 0.23, as per the TMX portal data. 

Ocugen reported cash, cash equivalents, and restricted cash amounted to US$ 19.3 million at the end of the third quarter of 2020, against US$ 7.6 million last year. The company currently has over 162 million outstanding listed shares and a current market capitalization of nearly US$ 130 million.

Lightspeed POS Inc. (TSX:LSPD)

Current Stock Price: C$ 86.65

 

The commerce-enabling SaaS service provider stock has soared nearly 118 per cent in the last three months. The software stock has returned almost 141 per cent this year.

LSPD holds a current market capitalization of approximately C$ 8.86 billion. The stock has a P/B ratio of 27.82 and a D/E ratio of 0.07, as per TMX data.

The cloud company stock made it to TMX’s top price performers that have outperformed the market (the TSX and TSXV) with the largest price gains across in the last 30 days. Lightspeed scrips rank among TMX’s top tech companies that have surpassed their peers in the last 30 days.

In the second quarter of fiscal 2021, which ended on 30 September, the tech firm recorded revenue of US$ 45.5 million, a surge of 62 per cent year-over-year.  The company generated record revenue from payments with a massive 300 per cent growth year-over-year in the quarter.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.